Altre lingue Guangxi Wuzhou Zhongheng Group Co.,Ltd

Azioni

600252

CNE0000015F9

Prezzo di chiusura Shanghai S.E. Altri mercati azionari 00:00:00 20/05/2024			Variaz. 5gg	Var. 1 gen.
2,46 ^CNY	0,00%		+0,41%	-1,99%

29/04	Guangxi Wuzhou Zhongheng Group Co.,Ltd riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
17/04	Guangxi Wuzhou Zhongheng Group Co.,Ltd (SHSE:600252) inizia un riacquisto di azioni per un valore di 200 milioni di CNY, in base all'autorizzazione approvata il 28 marzo 2024.	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Guangxi Wuzhou Zhongheng Group Co.,Ltd commences an Equity Buyback for CNY 200 million worth of its shares, under the authorization approved on March 28, 2024.	17/04
Guangxi Honggui Capital Operation Group Co.,Ltd. agreed to acquire 18% stake in Guangxi United Asset Management Co., Ltd from Guangxi Wuzhou Zhongheng Group Co.,Ltd for approximately CNY 190 million.	09/04
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	29/03
Lummy Pharma Gets Nod to Raise Dosage of Gastric Drug	18/03
Wuzhou Zhongheng’s Drug For Preventing Chemotherapy-Related Nausea Passes Consistency Test	10/11
Sealand Securities Co., Ltd. announced that it has received CNY 3.192189985 billion in funding from a group of investors	10/11
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23
Guangxi Wuzhou Zhongheng Group Co.,Ltd(XSSC:600252) added to S&P Global BMI Index	18/09/23
Guangxi Wuzhou Zhongheng Group Co.,Ltd(XSSC:600252) added to FTSE All-World Index	18/09/23
Wuzhou Zhongheng Gets Nod to Trial Ovarian Cancer Drug	15/09/23
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23
Guangxi Wuzhou Zhongheng Receives 42 Million Yuan in Government Subsidy	17/08/23
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	28/03/23
Restrictions on Guangxi Wuzhou Zhongheng Drugs in 2022 Chinese Drug Catalogue Amended	24/01/23
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	28/10/22
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	26/08/22
Guangxi Wuzhou Zhongheng Group Co.,Ltd(XSSC:600252) dropped from S&P Global BMI Index	20/06/22
Guangxi Wuzhou Zhongheng Group Co.,Ltd(XSSC:600252) dropped from FTSE All-World Index	13/06/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Guangxi Wuzhou Zhongheng Group Co.,Ltd

Azioni

600252

CNE0000015F9

Altre lingue

Filtri